Skip to main content
News Icon

News categories: Honors & Funding

Success in the "Advanced Clinician Scientist" proposal

Researching medical professionals receive funding from the BMBF

The Medical Faculty of the University of Bonn and the University Hospital Bonn (UKB) will be in the next five years part of the tender "Advanced Clinician Scientist" (ACS) of the Federal Ministry of Education and Research (BMBF) in the areas of immunopathogenesis and organ dysfunction as well as brain and neurodegeneration. The Medical Faculty and the UKB will receive around 9,000,000 euros for the project, with which the "ACCENT" (Advanced Clinician Scientist Program Bonn) will be set up. The innovative concept supports research specialists with a focus on immunology, neurosciences, genetics and epidemiology as well as cardiovascular diseases and oncology. For this purpose, in addition to their clinical work, they are closely linked to research associations such as Collaborative Research Centers and the ImmunoSensation² cluster of excellence through co-affiliation with research institutes.

The aim of the BMBF initiative is to increase career prospects in research and health care through the funding of Advanced Clinician Scientists (ACS) positions in university medicine throughout Germany. To this end, 12 ACS positions will be created in Bonn over the next three years. In addition, two other positions in Bonn are financed by the ImmunoSsensation² excellence cluster. In addition to interdisciplinary work and individual offers in the areas of coaching, mentoring and management training, ACCENT also focuses on equal opportunities and the compatibility of work and family. This ensures, among other things, that at least 50 percent of the participants are female.

Co-spokeswoman Prof. Annkristin Heine and member of the Cluster of Excellence ImmunoSensation says: "For the participating physicians, our program represents a great opportunity to both sharpen their scientific profile and their clinical goals, thanks to the 50 percent exemption from clinical work in favor of research follow. Support with administrative tasks, cooperation with basic science institutes and structured career development are specifically promoted. "

Related news

Prof. Dr. Frank G. Holz – Director of the Department of Ophthalmology at the University Hospital Bonn (UKB) and Professor at the University of Bonn.

News categories: Honors & Funding

Frank Holz Nominated for the Science Breakthrough of the Year 2026

A remarkable achievement for the Faculty of Medicine at the University of Bonn: Prof. Dr. Frank G. Holz, Director of the Department of Ophthalmology at the UKB and Professor at the University of Bonn, has been shortlisted for the Falling Walls Science Breakthrough of the Year 2026 in the Life Sciences category. His project is now among the 30 most outstanding scientific innovations worldwide in this category, recognized by the prestigious Falling Walls Science Summit. Being shortlisted alone represents a significant international distinction.
View entry
Prof. Dr. Elvira Mass (left) and Prof. Dr. Tatjana Tchumatchenko (right)

News categories: Honors & Funding

Hunting for New Angles

New research questions often arise where different methods, mindsets and subject-specific cultures meet, and it is these kinds of encounter that Professor Elvira Mass and Professor Tatjana Tchumatchenko want to make happen in a targeted way in future. The two researchers have been picked as Henriette Herz Scouts by the Alexander von Humboldt Foundation.
View entry
Precise Konsortium

News categories: Publication Honors & Funding

Making Cancer Cells More Predictable: PRECISE Aims to Forecast Therapeutically Actionable Vulnerabilities

Which genes and signaling pathways does a cancer cell require to survive? And which of these could serve as therapeutic targets? The pan-European initiative PRECISE aims to identify such vulnerabilities not only through labor-intensive laboratory experiments but also by predicting them using computational models. The UKB and the University of Bonn, represented by Prof. Dr. Maximilian Billmann and Prof. Dr. Jonathan Schmid-Burgk, are among the founding partners of the consortium. The scientific vision of the initiative has now been published in a commentary in Nature Genetics.
View entry

Back to the news overview